Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan, People's Republic of China.
Nat Biomed Eng. 2020 Sep;4(9):853-862. doi: 10.1038/s41551-020-0582-1. Epub 2020 Jul 6.
Patients with kidney failure commonly require dialysis to remove nitrogenous wastes and to reduce burden to the kidney. Here, we show that a bacterial cocktail orally delivered in animals with kidney injury can metabolize blood nitrogenous waste products before they diffuse through the intestinal mucosal barrier. The microbial cocktail consists of three strains of bacteria isolated from faecal microbiota that metabolize urea and creatinine into amino acids, and is encapsulated in calcium alginate microspheres coated with a polydopamine layer that is selectively permeable to small-molecule nitrogenous wastes. In murine models of acute kidney injury and chronic kidney failure, and in porcine kidney failure models, the encapsulated microbial cocktail significantly reduced urea and creatinine concentrations in blood, and did not lead to any adverse effects.
肾衰竭患者通常需要透析来清除氮废物,并减轻肾脏负担。在这里,我们表明,一种在肾损伤动物中口服给予的细菌混合物可以在血液氮废物扩散穿过肠黏膜屏障之前将其代谢。该微生物混合物由从粪便微生物群中分离出的三种细菌菌株组成,可将尿素和肌酸转化为氨基酸,并封装在包被有聚多巴胺层的海藻酸钙微球中,该聚多巴胺层对小分子氮废物具有选择性渗透性。在急性肾损伤和慢性肾衰竭的小鼠模型中,以及在猪肾衰竭模型中,包封的微生物混合物可显著降低血液中的尿素和肌酐浓度,并且不会引起任何不良反应。